24 Participants Needed

Tailored Adherence Program for Young Adults with Cancer

Recruiting at 2 trial locations
ME
Overseen ByMeghan E McGrady, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital Medical Center, Cincinnati
Must be taking: Oral chemotherapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

A pilot feasibility randomized clinical trial comparing a tailored intervention to uniform standard of care will be conducted. A total of 40 AYAs with cancer will be randomized to one of the two programs. Data will be collected to explore the hypotheses that the intervention meets pre-established enrollment, retention, fidelity, and data completion feasibility criteria and that AYAs will rate the intervention as easy to use and acceptable.

Research Team

ME

Meghan E McGrady, PhD

Principal Investigator

Children's Hospital Medical Center, Cincinnati

Eligibility Criteria

This trial is for adolescents and young adults aged 15-24 with cancer who are prescribed oral chemotherapy or prophylactic medication. They must be fluent in English without significant cognitive deficits, as judged by their medical team, and willing to use an electronic monitoring device. Those already showing high adherence (95% or more) during a preliminary period won't qualify.

Inclusion Criteria

I am taking oral chemotherapy or medication to prevent illness.
I have been diagnosed with cancer.
I am between 15 and 24 years old.

Exclusion Criteria

I am not fluent in English.
Patient evidences significant cognitive deficits per medical team
My doctor, caregiver, or I have decided I can't join due to my health or treatment.
See 2 more

Treatment Details

Interventions

  • Feedback Program
  • Tailored Program
Trial OverviewThe study tests a tailored program against the standard uniform care to improve medication adherence in young cancer patients. It's designed to see if the new approach is feasible, easy to use, acceptable, and meets certain criteria regarding enrollment, retention, fidelity of implementation, and data completion.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Tailored ProgramExperimental Treatment1 Intervention
8-week tailored program including 4 coach visits and 4 bi-weekly text check-ins
Group II: Feedback ProgramExperimental Treatment1 Intervention
8-week feedback program including 8 weekly texts

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital Medical Center, Cincinnati

Lead Sponsor

Trials
844
Recruited
6,566,000+

St. Jude Children's Research Hospital

Collaborator

Trials
451
Recruited
5,326,000+

Seattle Children's Hospital

Collaborator

Trials
319
Recruited
5,232,000+

University of Cincinnati

Collaborator

Trials
442
Recruited
639,000+